EA201590600A1 - Дигидропирролидинопиримидины в качестве ингибиторов киназы - Google Patents
Дигидропирролидинопиримидины в качестве ингибиторов киназыInfo
- Publication number
- EA201590600A1 EA201590600A1 EA201590600A EA201590600A EA201590600A1 EA 201590600 A1 EA201590600 A1 EA 201590600A1 EA 201590600 A EA201590600 A EA 201590600A EA 201590600 A EA201590600 A EA 201590600A EA 201590600 A1 EA201590600 A1 EA 201590600A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- present
- cancer
- dihydropyrrolidinopyrimidines
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/527—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Abstract
Настоящее изобретение относится к соединениям формулы (I) и их фармацевтически приемлемым солям; как дополнительно описано в настоящем изобретении. Кроме того, настоящее изобретение относится к фармацевтическим композициям, содержащим данные соединения и комбинации, содержащие данные соединения, смешанные с или применяемые с совместно вводимым терапевтическим агентом, а также терапевтическим применениям данных соединений и композиций. Они являются пригодными в лечении заболеваний, таких как рак, который связан с активацией ERK1 и/или ERK2, и особенно рака, зависящего от MAPK пути, проявляющего устойчивость к Raf и/или MEK ингибирующим противораковым терапевтическим средствам.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261702981P | 2012-09-19 | 2012-09-19 | |
PCT/US2013/060032 WO2014047020A1 (en) | 2012-09-19 | 2013-09-17 | Dihydropyrrolidino-pyrimidines as kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201590600A1 true EA201590600A1 (ru) | 2015-07-30 |
Family
ID=49274870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201590600A EA201590600A1 (ru) | 2012-09-19 | 2013-09-17 | Дигидропирролидинопиримидины в качестве ингибиторов киназы |
Country Status (13)
Country | Link |
---|---|
US (1) | US9546173B2 (ru) |
EP (1) | EP2897961B1 (ru) |
JP (1) | JP6186440B2 (ru) |
KR (1) | KR20150056550A (ru) |
CN (1) | CN104640865B (ru) |
AU (1) | AU2013318283A1 (ru) |
BR (1) | BR112015005982A2 (ru) |
CA (1) | CA2882410A1 (ru) |
EA (1) | EA201590600A1 (ru) |
ES (1) | ES2612885T3 (ru) |
IN (1) | IN2015DN01328A (ru) |
MX (1) | MX2015003535A (ru) |
WO (1) | WO2014047020A1 (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9546173B2 (en) * | 2012-09-19 | 2017-01-17 | Novartis Ag | Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors |
EP3820567A1 (en) | 2018-07-12 | 2021-05-19 | UCB Biopharma SRL | Spirocyclic indane analogues as il-17 modulators |
WO2020243457A1 (en) * | 2019-05-29 | 2020-12-03 | Viogen Biosciences, Llc | Compounds and therapeutic uses thereof |
KR20220042184A (ko) * | 2019-08-01 | 2022-04-04 | 프레테고 인코포레이티드 | 최종 당화 산물의 억제제 |
JP2023505300A (ja) * | 2019-12-10 | 2023-02-08 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | パラドックス遮断剤としての新規braf阻害剤 |
US11718610B2 (en) | 2020-04-30 | 2023-08-08 | Medshine Discovery Inc. | Compounds containing benzosultam |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60330485D1 (de) * | 2002-07-15 | 2010-01-21 | Merck & Co Inc | Zur behandlung von diabetes |
JP2007524596A (ja) | 2003-02-28 | 2007-08-30 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 共結晶医薬組成物 |
EP1697375A2 (en) * | 2003-12-02 | 2006-09-06 | Vertex Pharmaceuticals Incorporated | Heterocyclic protein kinase inhibitors and uses thereof |
PE20060426A1 (es) | 2004-06-02 | 2006-06-28 | Schering Corp | DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa |
AU2005323797B2 (en) | 2005-01-10 | 2009-07-09 | Pfizer Inc. | Pyrrolopyrazoles, potent kinase inhibitors |
RS51981B (en) | 2005-12-13 | 2012-02-29 | Schering Corporation | POLYCYCLIC INDASOL DERIVATIVES WHICH ARE ERK INHIBITORS |
BRPI0812450A2 (pt) | 2007-06-05 | 2019-09-24 | Schering Corp | derivados de indazol policíclicos e seu uso como inibidores de erk para o tratamento de câncer |
US8946216B2 (en) | 2010-09-01 | 2015-02-03 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
US9242981B2 (en) * | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
RU2013126036A (ru) | 2010-11-17 | 2014-12-27 | Ф. Хоффманн-Ля Рош Аг | Способ лечения опухолей |
MX339873B (es) | 2011-02-28 | 2016-06-15 | Genentech Inc | Inhibidores de serina/treonina cinasa. |
SG11201405055TA (en) | 2012-03-02 | 2014-09-26 | Genentech Inc | Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives |
US9546173B2 (en) * | 2012-09-19 | 2017-01-17 | Novartis Ag | Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors |
-
2013
- 2013-09-17 US US14/428,546 patent/US9546173B2/en active Active
- 2013-09-17 KR KR1020157006602A patent/KR20150056550A/ko not_active Application Discontinuation
- 2013-09-17 CA CA2882410A patent/CA2882410A1/en not_active Abandoned
- 2013-09-17 ES ES13771007.5T patent/ES2612885T3/es active Active
- 2013-09-17 EA EA201590600A patent/EA201590600A1/ru unknown
- 2013-09-17 CN CN201380048493.XA patent/CN104640865B/zh active Active
- 2013-09-17 EP EP13771007.5A patent/EP2897961B1/en active Active
- 2013-09-17 JP JP2015533126A patent/JP6186440B2/ja active Active
- 2013-09-17 MX MX2015003535A patent/MX2015003535A/es unknown
- 2013-09-17 BR BR112015005982A patent/BR112015005982A2/pt not_active IP Right Cessation
- 2013-09-17 AU AU2013318283A patent/AU2013318283A1/en not_active Abandoned
- 2013-09-17 IN IN1328DEN2015 patent/IN2015DN01328A/en unknown
- 2013-09-17 WO PCT/US2013/060032 patent/WO2014047020A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2013318283A1 (en) | 2015-03-05 |
EP2897961A1 (en) | 2015-07-29 |
JP2015529248A (ja) | 2015-10-05 |
CN104640865B (zh) | 2018-05-11 |
CA2882410A1 (en) | 2014-03-27 |
EP2897961B1 (en) | 2016-10-26 |
CN104640865A (zh) | 2015-05-20 |
ES2612885T3 (es) | 2017-05-19 |
US9546173B2 (en) | 2017-01-17 |
KR20150056550A (ko) | 2015-05-26 |
US20150274733A1 (en) | 2015-10-01 |
BR112015005982A2 (pt) | 2017-07-04 |
JP6186440B2 (ja) | 2017-08-23 |
WO2014047020A1 (en) | 2014-03-27 |
MX2015003535A (es) | 2015-07-14 |
IN2015DN01328A (ru) | 2015-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
EA201891203A1 (ru) | Гетероциклические соединения в качестве иммуномодуляторов | |
EA201591051A1 (ru) | Ингибиторы erk и варианты их применения | |
EA201690598A1 (ru) | Аминогетероарил бензамиды в качестве ингибиторов киназы | |
EA201891103A1 (ru) | Композиции для лечения спинальной мышечной атрофии | |
EA201500394A1 (ru) | Ингибиторы деметилаз гистонов | |
EA201691590A1 (ru) | Бензимидазол-2-амины в качестве ингибиторов midhi | |
MD20170016A2 (ru) | Аминопиримидиновые соединения в качестве ингибиторов JAK | |
EA201590748A1 (ru) | Противовирусные соединения против rsv | |
GEP20166484B (en) | Protein kinase inhibitors | |
EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
BR112015021983A8 (pt) | compostos heterocíclicos, composições e usos dos mesmos | |
EA201300684A1 (ru) | Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1 | |
EA201792421A1 (ru) | Амидозамещенные производные циклогексана | |
PH12014502040A1 (en) | Heterocyclyl compounds | |
EA201891063A1 (ru) | Производные дигидроимидазопиразинона, применимые в лечении рака | |
EA201590600A1 (ru) | Дигидропирролидинопиримидины в качестве ингибиторов киназы | |
EA201401351A1 (ru) | Производные бензимидазол-пролина | |
EA201790599A1 (ru) | Соединения и композиции в качестве ингибиторов киназ | |
EA201201658A1 (ru) | Производные пиперидина и их применение для лечения метаболических нарушений | |
BR112014028954A2 (pt) | amidas de n-piridinila substituídas no anel como inibidores da quinase | |
EA201691032A1 (ru) | Производные изохромена в качестве ингибиторов фосфоинозитид-3-киназ | |
MX340985B (es) | Compuestos de n-heteroarilo. | |
EA201890331A1 (ru) | Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена | |
EA201600434A1 (ru) | Применение производных бензимидазолпролина |